It is feasible that the primary title of the record Afibrinogenemia, Congenital is not the name you anticipated.
Genetic Afibrinogenemia is an unusual condition defined by lack of a specific drug (healthy protein) in the blood that is crucial in the blood clot (coagulation) procedure. This healthy protein is referred to as fibrinogen or coagulation element I. Affected people might be prone to serious blood loss (hemorrhaging) episodes, especially throughout early stage as well as youth. Hereditary Afibrinogenemia is believed to be sent as an autosomal recessive attribute.